Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bio-Reference Laboratories, Inc. Again Awarded New York State Department of Corrections Laboratory Services Contract.


Continuation of contract that was first initiated in 1998 remains with BioReference

ELMWOOD PARK, N.J. -- Bio-Reference Laboratories, Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
: BRLI BRLI Bio Rad Laboratories Inc ) announced today that the State of New York New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
 Department of Correctional Services has once again selected BRLI to be the Department's provider of Statewide Laboratory Services. Pursuant to its internal requirements, the Department submits its contract for laboratory services for bid and proposal every five (5) years. The State first went to a unified statewide contract for laboratory services in 1998 and since that time BRLI has continuously been the provider of laboratory services. Over the next five years, BRLI indicated that it expects revenues from this Contract to exceed $35M.

About BioReference Laboratories, Inc.

BRLI is the third largest full service laboratory in the United States and the largest independent regional laboratory in the Northeastern market, primarily a clinical testing lab servicing physician offices with concentrations in the focused markets of esoteric testing, molecular diagnostics, anatomical pathology anatomical pathology
n.
The study of the structural and compositional changes that occur in organs and tissues as a result of disease. Also called pathological anatomy.
 and correctional health care. BRLI operates as a national oncology laboratory under its GenPath label. Better science, superior technology and better service have enabled GenPath to earn a reputation as one of the premier hematopathology laboratories in the country. BRLI's innovative technology platform for sexually transmitted infections has enabled it to expand as a national laboratory in the area of Women's Health Women's Health Definition

Women's health is the effect of gender on disease and health that encompasses a broad range of biological and psychosocial issues.
. GeneDx, a wholly owned subsidiary Wholly Owned Subsidiary

A subsidiary whose parent company owns 100% of its common stock.

Notes:
In other words, the parent company owns the company outright and there are no minority owners.
, is the BRLI genetics laboratory and is typically recognized as the leading laboratory for testing of rare genetic diseases; GeneDx has now become a technology leader with GenomeDx, based on a CGH CGH Comparative Genomic Hybridization
CGH Changi General Hospital (Singapore)
CGH Computer-Generated Hologram
CGH Community General Hospital (Syracuse, NY) 
 array platform and its NextGen sequence offerings that are currently offered in cardiology and will be offered in the future in other disease specific areas.

Statements included in this release that are not historical in nature, are intended to be, and are hereby identified as "forward-looking statements". Statements looking forward in time are included in this release pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. Such statements involve known and unknown risks and uncertainties that may cause the Company's actual results in future periods to be materially different from any future performance suggested herein.

www.bioreference.com
COPYRIGHT 2009 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 5, 2009
Words:362
Previous Article:URS to Participate in the KeyBanc Capital Markets Engineering & Construction Conference.
Next Article:Welch Allyn's John Moran Recognized at 2009 HIDA MedSurg Conference and Expo.
Topics:



Related Articles
Bio-Reference Laboratories Receives Riker's Island - NY - Lab Contract; Extends New York State Prison's Contract; Contracts Valued at Approximately...
Bio-Reference Laboratories, Inc. Awarded Eastern Pennsylvania Prison Lab Contract.
Bio-Reference Laboratories Announces FDNY Laboratory Testing Contract; New York City Fire Department Contract Valued at nearly $5M.
Bio-Reference Laboratories Announces FDNY Testing; BRLI begins performing FDNY laboratory testing as part of "WTC Cough" program.
Bio-Reference Announces New Correctional Healthcare Services Contracts.
Bio-Reference Laboratories Awarded New York State Prison Contract for Fifth Consecutive Year; Contract Valued at Approximately $7M.
Government contracts.
Bio-Reference Laboratories, Inc. Announces Contract with Correctional Medical Services.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles